Return Home

IA2030 Scorecard — 

Global View

Impact Goal 2: Promote Equity
2.2

Provide access to all vaccines

What Does this Indicator Measure?

Introduction of new or underutilized vaccines in low- and middle-income countries.

How Will Progress be Measured?

The target is 500 vaccine introductions in low- and middle-income countries by 2030, including current new or under-utilized vaccine introductions (NUVI) as well as vaccines that will be recommended over the decade. Progress will be evaluated annually.

Introduction of new or underutilized vaccines in low- and middle-income countries—Global

Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030

Summary Table

Vaccine introductions2020
Total29
Covid4
DTP Booster0
HepB BD1
HiB0
HPV4
IPV24
PCV2
Rotavirus5
Rubella0
Cholera0
Hep A1
Influenza5
JE0
MenA0
Multivariant Men0
Mumps1
Rabies0
Typhoid0
Varicella0
Yellow Fever0
MCV22
Definition: Introductions are defined as addition of a vaccine to the national immunization schedule and use of the vaccine for a sustained period of at least 12 months (excludes vaccines used only in the private sector that are not in national immunization schedule; includes vaccines in national immunization schedules that are used in at-risk populations, e.g., seasonal influenza).

New or underutilized vaccines are defined as vaccines that have not yet been introduced into national immunization schedules in all countries where recommended by WHO.

Measurement approach: Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in all countries: HepB birth dose, Hib, HPV, IPV2, MCV2, PCV, rotavirus, rubella, DTP booster (currently reporting the fourth dose at any age), and COVID-19 (interim recommendation). Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in countries in certain geographic region(s), in some high-risk populations, or in immunization programmes with certain characteristics: YF, JE, MenA, multivariate meningitis, typhoid, cholera, dengue, rabies, HepA, influenza, varicella, and mumps.
Calculation: Count of the number of country vaccine introductions for WHO recommended vaccines reported from 2021-2030.